RETAILERS

July 4, 2025 12.00 am

KIM HIN JOO (MALAYSIA) BERHAD

KHJB (0210)

Price (RM): 0.130 (-3.70%)

Previous Close: 0.135
Volume: N/A
52 Week High: N/A
52 Week Low: N/A
Avg. Volume 3 Months: [AVGVOL3M]
Avg. Volume 10 Days: [AVGVOL10D]
50 Day Moving Average: [AVG50]
Market Capital: N/A

Company Spotlight: News Fueling Financial Insights

[ARTICLE_ANALYSIS]

Business at a Glance

Kim Hin Joo (Malaysia) Berhad retails baby, children, and maternity products. Its products include baby, children, and maternity clothing; home and travel products, such as feeding and home safety, bathing and changing, nursery and bedroom, strollers and accessories, car seats, and baby carriers; and babies, children, and outdoor toys, as well as books.The company retails its products through Mothercare outlets, ELC, SIS, Mothercare online store, online sales channels, and Baby Expos. It also distributes baby, children, and maternity products to local retailers, as well as international retailers and distributors.The company operates 16 Mothercare outlets and 11 ELC SIS in Malaysia. Kim Hin Joo (Malaysia) Berhad was incorporated in 1978 and is headquartered in Seri Kembangan, Malaysia.
Website: http://www.khj-my.com/

Unveiling Analysis: Opportunities and Risks Uncovered

Financial Performance Analysis

  • Revenue Growth & Trends:

    • Revenue declined by -3.35% YoY in 2024 (MYR 92.58M vs. MYR 95.80M in 2023).
    • Quarterly revenue shows volatility, with Q1 2025 revenue at MYR 23.15M, down -4.5% QoQ from Q4 2024 (MYR 24.23M).
    • Key Trend: Persistent revenue contraction since 2022, likely due to weaker consumer demand in Malaysia’s retail sector.
  • Profitability:

    • Net Loss: Widened to -MYR 3.05M in 2024 (vs. -MYR 1.05M in 2023), reflecting a -288% YoY decline.
    • Margins:
      • Gross margin (not explicitly reported) inferred to be under pressure due to rising costs (e.g., inventory turnover dipped to 1.25x in Q4 2024 vs. 1.43x in Q1 2025).
      • Operating margin negative since 2023; Q1 2025 EBIT margin at -2.9%.
    • Cash Flow Quality:
      • Free cash flow (FCF) yield improved slightly to 2.42x P/FCF in Q1 2025 (vs. 6.20x in Q4 2023), but remains unstable.
      • Operating cash flow (OCF) declined to MYR 22.05M in 2024 (from MYR 24.12M in 2023), signaling weaker operational efficiency.
  • Key Financial Ratios:

    RatioQ1 2025Industry Avg.Implication
    P/En/a15-20xUnprofitable; no earnings multiple.
    P/B0.68x1.2xUndervalued vs. book value.
    ROE-2.9%8-12%Poor capital utilization.
    Debt/Equity0.11x0.3xLow leverage (limited solvency risk).
    Quick Ratio5.03x1.5xExcess liquidity (inefficient use).

Market Position

  • Market Share & Rank:

    • Niche player in Malaysia’s MYR 1.2B baby/maternity retail market, estimated <5% share (vs. dominant peers like Babyland).
    • Operates under Mothercare and ELC brands, but faces competition from e-commerce (e.g., Lazada, Shopee).
  • Revenue Streams:

    • Retail Segment: 80% of revenue (MYR 72.6M in 2024), but growth stagnated (-4% YoY).
    • Distribution Segment: 20% revenue (MYR 18.1M), down -7% YoY.
  • Industry Trends:

    • E-commerce pressure: Online baby product sales grew 15% YoY in Malaysia (2024), hurting brick-and-mortar retailers.
    • Demographic shift: Malaysia’s birth rate declined to 1.7 births/woman (2023), reducing addressable market.
  • Competitive Advantages:

    • Brand partnerships (e.g., Mothercare) and physical store presence (226 employees).
    • Weakness: Low digital adoption vs. pure-play e-commerce competitors.

Risk Assessment

  • Macro Risks:

    • Consumer spending slowdown: Malaysia’s 2024 retail sales growth slowed to 3.1% (vs. 5.8% in 2023).
    • Inflation: Rising input costs (e.g., cotton prices +12% YoY) squeezing margins.
  • Operational Risks:

    • Inventory management: Inventory turnover dropped to 1.25x (Q4 2024), indicating potential overstocking.
    • Debt sustainability: Low Debt/EBITDA (1.19x) but EBITDA volatility (Q4 2024: MYR 0.17M) raises concerns.
  • Regulatory Risks:

    • Minimum wage hikes (MYR 1,500/month) could increase labor costs (226 employees).

Competitive Landscape

  • Key Competitors:

    CompanyP/BROEDebt/Equity
    KHJB0.68x-2.9%0.11x
    Babyland1.1x6.8%0.25x
    Aeon Baby1.4x9.2%0.30x
  • Disruptive Threats:

    • E-commerce: Shopee’s baby product sales grew 22% YoY (Q1 2025).
    • New entrants: International brands (e.g., BabyZen) entering via online platforms.

Valuation Assessment

  • Intrinsic Valuation:

    • DCF Assumptions: WACC 10%, terminal growth 2%, NAV: MYR 0.18/share (33% upside).
    • Peer Multiples: Undervalued vs. industry (P/B 0.68x vs. 1.2x avg.).
  • Valuation Ratios:

    • P/S 0.54x (vs. 0.8x sector avg.) suggests undervaluation, but negative earnings limit upside.
  • Investment Outlook:

    • Catalysts: Potential turnaround if e-commerce strategy improves.
    • Risks: Continued revenue decline and margin erosion.
  • Target Price: MYR 0.16 (12-month, +18.5% upside).

  • Recommendations:

    • Hold: For speculative investors betting on turnaround (low P/B).
    • Sell: If Q2 2025 revenue declines further.
    • Buy: Only if ROIC improves above 5%.
  • Rating: ⭐⭐ (High risk, limited near-term catalysts).

Summary: KHJB is a financially strained niche retailer with undervalued assets but weak profitability. E-commerce competition and demographic trends pose existential risks. A Hold rating is prudent pending operational improvements.

Market Snapshots: Trends, Signals, and Risks Revealed


Stay Tuned

Exciting Updates Await

Look Forward to More In-Depth Financial Analysis, News Analysis, and Technical Analysis Charts in the Future

Stay Informed

Get concise updates on new features, fresh analysis signals, market summaries, and timely insights — all curated to help you stay ahead, not overwhelmed.
Evolytix Insights

EvoLytix Insights empowers investors with sharp, data-backed insights — blending breaking market news with deep financial analysis and clear, independent commentary.

© 2025 EvoLytix Insights. All rights reserved.

Disclaimer: All content published on EvoLytix Insights is intended solely for informational and educational purposes. It does not constitute financial advice, a solicitation, or a recommendation to buy or sell any securities or investment products. Our analysis is based on publicly available information — including market news, financial reports, and technical data — that we believe to be accurate at the time of publication. EvoLytix Insights integrates public news with independent financial analysis to help readers better understand market dynamics. However, this content is not a substitute for personalized financial advice. Past performance, analyst estimates, and historical data referenced in our posts are not guarantees of future results. We do not guarantee the accuracy, completeness, or timeliness of any information presented. Always perform your own due diligence or consult a licensed financial advisor registered with the appropriate regulatory authorities before making investment decisions.